Lauren Ashley Henderson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphohistiocytosis, Hemophagocytic | 10 | 2023 | 260 | 3.280 |
Why?
|
Macrophage Activation Syndrome | 9 | 2023 | 111 | 3.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 11 | 2023 | 611 | 2.700 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2019 | 547 | 1.240 |
Why?
|
Rheumatology | 4 | 2023 | 576 | 1.170 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 6 | 2023 | 546 | 1.050 |
Why?
|
Lung Diseases | 4 | 2023 | 1885 | 0.960 |
Why?
|
Pleurisy | 2 | 2013 | 53 | 0.900 |
Why?
|
Synovial Fluid | 4 | 2022 | 394 | 0.890 |
Why?
|
Autoimmunity | 4 | 2019 | 1349 | 0.710 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 264 | 0.700 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2023 | 2988 | 0.650 |
Why?
|
Eosinophilia | 1 | 2023 | 542 | 0.650 |
Why?
|
Cell Polarity | 1 | 2021 | 645 | 0.630 |
Why?
|
Severe Combined Immunodeficiency | 3 | 2015 | 223 | 0.570 |
Why?
|
Dyspnea | 2 | 2013 | 1303 | 0.520 |
Why?
|
Child | 36 | 2023 | 77679 | 0.500 |
Why?
|
Biological Products | 1 | 2023 | 860 | 0.480 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.460 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 2422 | 0.460 |
Why?
|
Antirheumatic Agents | 3 | 2021 | 1339 | 0.460 |
Why?
|
Uveitis | 1 | 2016 | 375 | 0.420 |
Why?
|
Leukopenia | 1 | 2012 | 208 | 0.420 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.410 |
Why?
|
T-Lymphocytes | 6 | 2022 | 10182 | 0.390 |
Why?
|
Inflammation | 7 | 2023 | 10634 | 0.370 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1789 | 0.370 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2023 | 986 | 0.360 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 297 | 0.340 |
Why?
|
Adenosine Deaminase | 2 | 2021 | 241 | 0.320 |
Why?
|
Child, Preschool | 18 | 2023 | 40992 | 0.310 |
Why?
|
Lung | 4 | 2022 | 9852 | 0.310 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2021 | 658 | 0.280 |
Why?
|
Immunomodulation | 2 | 2020 | 541 | 0.260 |
Why?
|
Humans | 56 | 2023 | 744220 | 0.250 |
Why?
|
Consensus | 4 | 2023 | 2958 | 0.250 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2023 | 131 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1676 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.200 |
Why?
|
Eczema | 1 | 2023 | 231 | 0.190 |
Why?
|
Adolescent | 14 | 2022 | 85759 | 0.190 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 237 | 0.190 |
Why?
|
Methotrexate | 2 | 2019 | 1720 | 0.190 |
Why?
|
Delphi Technique | 2 | 2021 | 778 | 0.190 |
Why?
|
Advisory Committees | 2 | 2023 | 774 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3311 | 0.180 |
Why?
|
Registries | 1 | 2016 | 8090 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4477 | 0.180 |
Why?
|
Interferon Type I | 1 | 2023 | 542 | 0.180 |
Why?
|
Interleukin-1 | 1 | 2023 | 1263 | 0.170 |
Why?
|
Immunophenotyping | 2 | 2021 | 1880 | 0.170 |
Why?
|
T-Lymphocyte Subsets | 2 | 2018 | 1838 | 0.170 |
Why?
|
Thrombophilia | 1 | 2021 | 305 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2021 | 507 | 0.160 |
Why?
|
Uveitis, Anterior | 1 | 2019 | 101 | 0.160 |
Why?
|
Receptors, IgG | 1 | 2022 | 582 | 0.160 |
Why?
|
Receptors, Interleukin-1 | 1 | 2019 | 262 | 0.160 |
Why?
|
B-Lymphocytes | 3 | 2023 | 4665 | 0.150 |
Why?
|
Serpins | 1 | 2019 | 247 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2021 | 4385 | 0.150 |
Why?
|
Infant | 8 | 2021 | 35129 | 0.150 |
Why?
|
Nitriles | 1 | 2022 | 952 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1836 | 0.140 |
Why?
|
Arthritis | 1 | 2022 | 659 | 0.140 |
Why?
|
Th1 Cells | 1 | 2021 | 1057 | 0.140 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12961 | 0.140 |
Why?
|
Tuberculosis, Bovine | 1 | 2015 | 9 | 0.140 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2015 | 19 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
Male | 21 | 2022 | 350027 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1477 | 0.130 |
Why?
|
Female | 24 | 2022 | 380197 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5442 | 0.130 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 518 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 140 | 0.120 |
Why?
|
Autoantibodies | 1 | 2023 | 2038 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 835 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2016 | 215 | 0.120 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2013 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3778 | 0.110 |
Why?
|
Cytokines | 4 | 2023 | 7326 | 0.110 |
Why?
|
Monocytes | 1 | 2022 | 2594 | 0.110 |
Why?
|
Adenylate Kinase | 1 | 2012 | 100 | 0.110 |
Why?
|
Candida albicans | 1 | 2015 | 394 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2023 | 77426 | 0.100 |
Why?
|
Pyrazoles | 1 | 2022 | 1973 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2018 | 2540 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1854 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1582 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2108 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.100 |
Why?
|
Histones | 1 | 2021 | 2600 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1102 | 0.090 |
Why?
|
Consanguinity | 1 | 2012 | 456 | 0.090 |
Why?
|
Pyrimidines | 1 | 2022 | 2940 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2021 | 25618 | 0.090 |
Why?
|
Adult | 11 | 2023 | 214035 | 0.090 |
Why?
|
Mutation | 6 | 2018 | 29784 | 0.090 |
Why?
|
Neutrophils | 1 | 2022 | 3717 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4151 | 0.090 |
Why?
|
Immunity | 1 | 2015 | 1012 | 0.080 |
Why?
|
Anticoagulants | 2 | 2021 | 4599 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 810 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1618 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3646 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39045 | 0.080 |
Why?
|
DNA Methylation | 1 | 2021 | 4289 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 20945 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7784 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 25043 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 21752 | 0.070 |
Why?
|
Syndrome | 1 | 2013 | 3250 | 0.070 |
Why?
|
Age of Onset | 1 | 2013 | 3270 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2022 | 3203 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5657 | 0.070 |
Why?
|
Cell Differentiation | 2 | 2021 | 11478 | 0.070 |
Why?
|
Pain Measurement | 3 | 2022 | 3419 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6485 | 0.070 |
Why?
|
Physicians | 1 | 2023 | 4564 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9647 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2702 | 0.060 |
Why?
|
Interleukin-17 | 2 | 2023 | 900 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3746 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2016 | 19227 | 0.060 |
Why?
|
Phenotype | 3 | 2022 | 16365 | 0.060 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2023 | 160 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17449 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5853 | 0.050 |
Why?
|
Family | 1 | 2013 | 3148 | 0.050 |
Why?
|
Algorithms | 2 | 2021 | 13885 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2022 | 130 | 0.050 |
Why?
|
Brain | 2 | 2019 | 26413 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 70 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 645 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 56436 | 0.050 |
Why?
|
Cathepsin G | 1 | 2021 | 32 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7022 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7281 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2136 | 0.050 |
Why?
|
Caspase 1 | 1 | 2022 | 224 | 0.050 |
Why?
|
Myeloblastin | 1 | 2021 | 101 | 0.050 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 113 | 0.050 |
Why?
|
Enzyme Assays | 1 | 2021 | 111 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8387 | 0.040 |
Why?
|
Thrombelastography | 1 | 2021 | 163 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2023 | 502 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 132 | 0.040 |
Why?
|
United States | 3 | 2023 | 69867 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2021 | 743 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3637 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 231 | 0.040 |
Why?
|
Risk Factors | 2 | 2023 | 72280 | 0.040 |
Why?
|
Immune System Diseases | 1 | 2021 | 263 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 249 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 494 | 0.040 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 54 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2019 | 224 | 0.040 |
Why?
|
Receptors, CXCR5 | 1 | 2017 | 92 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.040 |
Why?
|
Mice | 5 | 2022 | 81178 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 193 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1614 | 0.030 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2015 | 33 | 0.030 |
Why?
|
Epigenomics | 1 | 2021 | 903 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14556 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2461 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2016 | 258 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.030 |
Why?
|
Cephalometry | 1 | 2016 | 382 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2016 | 315 | 0.030 |
Why?
|
Mycobacterium bovis | 1 | 2015 | 150 | 0.030 |
Why?
|
Agammaglobulinemia | 1 | 2016 | 167 | 0.030 |
Why?
|
Granulocytes | 1 | 2016 | 547 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 793 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 669 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 342 | 0.030 |
Why?
|
Alleles | 2 | 2015 | 6938 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 450 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Knee Joint | 1 | 2021 | 1680 | 0.030 |
Why?
|
Interleukins | 1 | 2017 | 791 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2969 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4201 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2018 | 1119 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 805 | 0.020 |
Why?
|
Animals | 5 | 2022 | 168788 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6612 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1357 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1787 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3385 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2013 | 659 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2508 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3201 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2022 | 3591 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4776 | 0.020 |
Why?
|
Thymus Gland | 1 | 2015 | 1267 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3282 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2934 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3922 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1179 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6757 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4648 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2103 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5523 | 0.020 |
Why?
|
Middle Aged | 3 | 2019 | 213367 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4188 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4987 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6546 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9392 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3023 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4156 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12781 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7799 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5216 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2015 | 1832 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14726 | 0.020 |
Why?
|
Aging | 1 | 2022 | 8661 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15999 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21824 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9438 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13280 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29050 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20123 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35423 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63119 | 0.010 |
Why?
|